🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 3 Months
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(5133)
All (5133)
Buys (605)
Sells (4528)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Valion Bio, Inc.
(VBIO)
Valauri Christina Rizopoulos
— Director
Apr 1, 2026
Purchase
Shares
19,000
Price
$0.95
Total Value
$18.01K
Shares Held After
19,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CAPRICOR THERAPEUTICS, INC.
(CAPR)
Sabar Karimah Es
— Director
Apr 1, 2026
Sale
Shares
53,735
Price
$31.03
Total Value
$1.67M
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alkermes plc.
(ALKS)
Hopkinson Craig C.
— EVP R&D, Chief Medical Officer
Apr 1, 2026
Sale
Shares
9,000
Price
$35.51
Total Value
$319.60K
Shares Held After
85,389
% of Holdings
9.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Chadwick Jeremy G
— Chief Operating Officer
Apr 1, 2026
Sale
Shares
1,100
Price
$86.05
Total Value
$94.66K
Shares Held After
61,202
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Chadwick Jeremy G
— Chief Operating Officer
Apr 1, 2026
Sale
Shares
13,540
Price
$85.41
Total Value
$1.16M
Shares Held After
62,302
% of Holdings
17.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Ridloff Elena
— Director
Apr 1, 2026
Sale
Shares
1,200
Price
$86.05
Total Value
$103.26K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kymera Therapeutics, Inc.
(KYMR)
Ridloff Elena
— Director
Apr 1, 2026
Sale
Shares
3,400
Price
$85.19
Total Value
$289.66K
Shares Held After
1,200
% of Holdings
73.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
JOYCE CHRISTOPHER J
— Chief Legal and Admin. Officer
Apr 1, 2026
Sale
Shares
18,013
Price
$17.79
Total Value
$320.49K
Shares Held After
305,451
% of Holdings
5.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Clene Inc.
(CLNN)
Ugwumba Chidozie
— 10% Owner
Apr 1, 2026
Sale
Shares
4,278
Price
$4.97
Total Value
$21.26K
Shares Held After
426,816
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Blum Robert I
— Director
Apr 1, 2026
Sale
Shares
7,500
Price
$66.63
Total Value
$499.72K
Shares Held After
422,830
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Altimmune, Inc.
(ALT)
Durso Jerome Benedict
— Director
Apr 1, 2026
Purchase
Shares
15,000
Price
$3.14
Total Value
$47.10K
Shares Held After
47,500
% of Holdings
31.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Altimmune, Inc.
(ALT)
WEAVER GREGORY L
— Chief Financial Officer
Apr 1, 2026
Purchase
Shares
10,000
Price
$3.15
Total Value
$31.50K
Shares Held After
38,078
% of Holdings
26.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Sale
Shares
87
Price
$31.52
Total Value
$2.74K
Shares Held After
146,657
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Sale
Shares
5
Price
$28.41
Total Value
$142.03
Shares Held After
146,657
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Sale
Shares
57
Price
$27.11
Total Value
$1.55K
Shares Held After
146,657
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Sale
Shares
1,251
Price
$25.17
Total Value
$31.48K
Shares Held After
146,657
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Sale
Shares
191
Price
$24.28
Total Value
$4.64K
Shares Held After
146,657
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Purchase
Shares
411
Price
$32.60
Total Value
$13.40K
Shares Held After
146,657
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Purchase
Shares
1,957
Price
$31.45
Total Value
$61.55K
Shares Held After
146,657
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Purchase
Shares
186
Price
$30.48
Total Value
$5.67K
Shares Held After
146,657
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Purchase
Shares
17
Price
$27.78
Total Value
$472.32
Shares Held After
146,657
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Purchase
Shares
1,048
Price
$26.73
Total Value
$28.01K
Shares Held After
146,657
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Purchase
Shares
1,770
Price
$25.32
Total Value
$44.82K
Shares Held After
146,657
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sensei Biotherapeutics, Inc.
(SNSE)
MILLENNIUM MANAGEMENT LLC
— 10% Owner
Mar 31, 2026
Purchase
Shares
616
Price
$24.69
Total Value
$15.21K
Shares Held After
146,657
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ADC Therapeutics SA
(ADCT)
Redmile Group, LLC
— 10% Owner
Mar 31, 2026
Sale
Shares
188,407
Price
$3.75
Total Value
$706.90K
Shares Held After
12,957,305
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ADC Therapeutics SA
(ADCT)
Redmile Group, LLC
— 10% Owner
Mar 31, 2026
Sale
Shares
196,229
Price
$3.75
Total Value
$736.25K
Shares Held After
15,470,502
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Canopy Growth Corp
(CGC)
Lazzarato David Angelo
— Director
Mar 31, 2026
Sale
Shares
15,624
Price
$0.93
Total Value
$14.53K
Shares Held After
72,048
% of Holdings
17.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Canopy Growth Corp
(CGC)
ATKINS M SHAN
— Director
Mar 31, 2026
Sale
Shares
2,074
Price
$0.93
Total Value
$1.93K
Shares Held After
41,390
% of Holdings
4.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Canopy Growth Corp
(CGC)
Yanofsky Theresa
— Director
Mar 31, 2026
Sale
Shares
10,373
Price
$0.93
Total Value
$9.65K
Shares Held After
53,145
% of Holdings
16.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Canopy Growth Corp
(CGC)
BAYERN JOSEPH
— Director
Mar 31, 2026
Sale
Shares
2,658
Price
$0.93
Total Value
$2.47K
Shares Held After
40,000
% of Holdings
6.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Vivos Therapeutics, Inc.
(VVOS)
Skaff Michael C
— 10% Owner
Mar 31, 2026
Purchase
Shares
308,848
Price
$1.34
Total Value
$413.86K
Shares Held After
1,353,625
% of Holdings
22.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Vivos Therapeutics, Inc.
(VVOS)
Skaff Michael C
— 10% Owner
Mar 31, 2026
Purchase
Shares
1,044,777
Price
$1.34
Total Value
$1.40M
Shares Held After
1,044,777
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mineralys Therapeutics, Inc.
(MLYS)
Karydas Daphne
— Director
Mar 31, 2026
Sale
Shares
3,000
Price
$25.00
Total Value
$75.00K
Shares Held After
6,200
% of Holdings
32.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Allogene Therapeutics, Inc.
(ALLO)
Beneski Benjamin Machinas
— SVP, Chief Technical Officer
Mar 31, 2026
Sale
Shares
2,867
Price
$2.50
Total Value
$7.17K
Shares Held After
195,338
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mineralys Therapeutics, Inc.
(MLYS)
Congleton Jon
— Director
Mar 31, 2026
Sale
Shares
453
Price
$27.05
Total Value
$12.25K
Shares Held After
705,051
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mineralys Therapeutics, Inc.
(MLYS)
Congleton Jon
— Director
Mar 31, 2026
Sale
Shares
55,183
Price
$26.54
Total Value
$1.46M
Shares Held After
705,504
% of Holdings
7.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mineralys Therapeutics, Inc.
(MLYS)
Congleton Jon
— Director
Mar 31, 2026
Sale
Shares
19,364
Price
$25.50
Total Value
$493.79K
Shares Held After
760,687
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Phreesia, Inc.
(PHR)
Pale Fire Capital SE
— 10% Owner
Mar 31, 2026
Purchase
Shares
1,000,500
Price
$8.16
Total Value
$8.16M
Shares Held After
8,649,329
% of Holdings
11.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Neal James R
— Director
Mar 31, 2026
Purchase
Shares
789
Price
$2.54
Total Value
$2.00K
Shares Held After
818
% of Holdings
96.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zenas BioPharma, Inc.
(ZBIO)
Lu Hongbo
— Director
Mar 31, 2026
Purchase
Shares
3,768
Price
$18.63
Total Value
$70.20K
Shares Held After
426,736
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
200
Price
$594.11
Total Value
$118.82K
Shares Held After
40,513
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
700
Price
$593.13
Total Value
$415.19K
Shares Held After
40,713
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
760
Price
$590.36
Total Value
$448.67K
Shares Held After
41,413
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
600
Price
$589.40
Total Value
$353.64K
Shares Held After
42,173
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
567
Price
$588.38
Total Value
$333.61K
Shares Held After
42,773
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
467
Price
$587.37
Total Value
$274.30K
Shares Held After
43,340
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
886
Price
$586.14
Total Value
$519.32K
Shares Held After
43,807
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
1,161
Price
$585.00
Total Value
$679.18K
Shares Held After
44,693
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
980
Price
$584.04
Total Value
$572.36K
Shares Held After
45,854
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 31, 2026
Sale
Shares
1,391
Price
$583.08
Total Value
$811.06K
Shares Held After
46,834
% of Holdings
2.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 3851–3900 of 5133 transactions (page 78 of 103)
Version: v26.5.2